MedTrace Logo

A Phase II Study to Evaluate the Efficacy of ThromboView® in the Detection of Pulmonary Emboli

NCT00519506 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2009-04-14

No results posted yet for this study

Summary

The aim of the study is to determine the diagnostic accuracy of 99mTc ThromboView® SPECT imaging for the detection of acute pulmonary embolism (PE) in patients for whom there is a moderate to high clinical suspicion for PE.

Conditions

  • Acute Pulmonary Embolism

Interventions

OTHER

ThromboView

Radiopharmaceutical, single dose, of the diagnosis of venous thromboembolism

Sponsors & Collaborators

  • Agen Biomedical

    lead INDUSTRY

Principal Investigators

  • Timothy Morris, MD · UCSD Medical Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2008-06-30
Completion
2008-10-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00519506 on ClinicalTrials.gov